Billionaires Buy a Brilliant Vanguard Index Fund That Could Turn $500 Per Month Into $442,400 With Help From the "Magnificent Seven" Stocks

Motley Fool
08/19
  • A few wealthy hedge fund managers added shares of the Vanguard Mega Cap Growth ETF in the second quarter.
  • The Vanguard Mega Cap Growth ETF has nearly 60% of its assets invested in "Magnificent Seven" stocks.
  • The Vanguard Mega Cap Growth ETF has returned 669% since its inception, compounding at 12.2% annually.

Recently filed Forms 13F indicate these billionaire-led hedge funds bought shares in the Vanguard Mega Cap Growth ETF (MGK -0.06%) during the second quarter:

  • Cliff Asness' AQR Capital Management added 6,205 shares, doubling its stake.
  • Ken Griffin's Citadel Advisors added 10,498 shares, starting a small position.
  • David Shaw's D.E. Shaw added 8,190 shares, starting a small position.

While none of these hedge funds have particularly large positions in the Vanguard Mega Cap Growth ETF, it's still a worthwhile holding as part of a diversified portfolio. The index fund provides heavy exposure to the "Magnificent Seven" stocks, and history says it can turn $500 per month into $442,400 in the next 20 years.

Image source: Getty Images.

Vanguard Mega Cap Growth ETF is heavily invested in the "Magnificent Seven" stocks

The Vanguard Mega Cap Growth ETF tracks 69 large U.S. companies that account for 70% of U.S. equities by market value. In particular, the index fund is focused on growth-oriented stocks in the technology sector, but a large percentage of its assets are also invested in the consumer discretionary sector.

Here are the top 10 holdings in the Vanguard Mega Cap Growth ETF, listed by weight:

  1. Nvidia: 14.4%
  2. Microsoft: 13.9%
  3. Apple: 10.8%
  4. Amazon: 7.7%
  5. Broadcom: 4.9%
  6. Meta Platforms: 4.6%
  7. Alphabet: 4.5%
  8. Tesla: 3.1%
  9. Eli Lilly: 2.3%
  10. Visa: 2.2%

The Vanguard Mega Cap Growth ETF has nearly 60% of its assets in the "Magnificent Seven" stocks, some of the most competitively advantaged and fundamentally sound companies in the world. Compared to the other 493 members of the S&P 500 (^GSPC -0.01%), the "Magnificent Seven" have consistently reported faster earnings growth, as detailed below:

  • The "Magnificent Seven" reported earnings growth of 31% in 2023, while the remaining 493 companies in the S&P 500 reported an earnings decline of 4%.
  • The "Magnificent Seven" reported earnings growth of 40% in 2024, while the remaining 493 companies in the S&P 500 reported an earnings decline of 4%.

More importantly, Wall Street analysts expect the "Magnificent Seven" to keep outperforming the other S&P 500 companies through at least 2026 as the artificial intelligence (AI) market expands.

The Vanguard Mega Cap Growth ETF could turn $500 per month into $442,400 in 20 Years

The Vanguard Mega Cap Growth ETF has returned 669% since its inception in December 2007, which is equivalent to 12.2% annually over the last 18 years. That period covers such a broad range of economic and market conditions -- two recessions, three bear markets, and eight market corrections -- that investors can reasonably expect similar returns in the future.

Assuming the index fund continues to gain 12.2% annually, $500 invested monthly would be worth $106,300 in one decade and $442,400 in two decades. But some investors may prefer to save more or less. The chart details how different monthly contribution amounts would grow over time, assuming the index fund returns 12.2% annually.

Holdings Period

$200 Per Month

$400 Per Month

$600 Per Month

Five years

$15,300

$30,600

$45,900

10 years

$42,500

$85,000

$127,500

20 years

$176,900

$353,900

$530,900

Returns determined with the investor.gov compound interest calculator. Table by author. 

The last item of consequence is the expense ratio. The Vanguard Mega Cap Growth ETF has a reasonable expense ratio of 0.07%, meaning shareholders will pay $7 per year on every $10,000 invested in the fund.

In summary, I would characterize this index fund as a cheap, easy way to get exposure to the largest U.S. stocks, including the Magnificent Seven.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10